I-Mab

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$0.59-$6.79
Market Cap
$533.6M
Shares Short
3M

Financials

See more
Revenue (12 Mos)
$3.4M
Revenue Growth (YoY)
-62.1%
Gross Profit (12 Mos)
$41.5M
Diluted EPS
-$0.51

News

See more

Yahoo Finance • 22 days ago

I-Mab To Present Positive Updated Givastomig Monotherapy Data at 2025 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference on October 23, 2025

Yahoo Finance • 27 days ago

I-Mab tumbles after announcing new business model

Yahoo Finance • 28 days ago

I-Mab Announces Intention to Undertake Strategic Transformation to Global Biotech Platform, to Pursue Hong Kong IPO, and Rebrand as NovaBridge Biosciences

Yahoo Finance • 30 days ago

I-Mab to Present Short-Talk on Updated Givastomig Monotherapy Data at the 2025 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference

About

CEO
Dr. Xi-Yong Fu M.B.A., Ph.D.
Address
2440 Research Boulevard, Rockville, MD, United States, 20850
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
32